|
1
|
Andreasen NC: Schizophrenia: the
fundamental questions. Brain Res Brain Res Rev. 31:106–112. 2000.
View Article : Google Scholar
|
|
2
|
Ho BC, Andreasen N and Flaum M: Dependence
on public financial support early in the course of schizophrenia.
Psychiatr Serv. 48:948–950. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hosak L: New findings in the genetics of
schizophrenia. World J Psychiatry. 3:57–61. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Do KQ: Schizophrenia: genes, environment
and neurodevelopment. Rev Med Suisse. 9(1672): 1674–1677. 2013.(In
French).
|
|
5
|
McGrath JJ, Mortensen PB, Visscher PM and
Wray NR: Where GWAS and epidemiology meet: opportunities for the
simultaneous study of genetic and environmental risk factors in
schizophrenia. Schizophr Bull. 39:955–959. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Feigenson KA, Kusnecov AW and Silverstein
SM: Inflammation and the two-hit hypothesis of schizophrenia.
Neurosci Biobehav Rev. 38:72–93. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Geoffroy PA, Etain B and Houenou J: Gene X
environment interactions in schizophrenia and bipolar disorder:
evidence from neuroimaging. Front Psychiatry. 4:1362013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Craddock N, O’Donovan MC and Owen MJ: The
genetics of schizophrenia and bipolar disorder: dissecting
psychosis. J Med Genet. 42:193–204. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kendler KS, McGuire M, Gruenberg AM,
O’Hare A, Spellman M and Walsh D: The Roscommon Family Study. I.
Methods, diagnosis of probands, and risk of schizophrenia in
relatives. Arch Gen Psychiatry. 50:527–540. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cardno AG, Marshall EJ, Coid B, et al:
Heritability estimates for psychotic disorders: the Maudsley twin
psychosis series. Arch Gen Psychiatry. 56:162–168. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Singh S, Kumar A, Agarwal S, Phadke SR and
Jaiswal Y: Genetic insight of schizophrenia: past and future
perspectives. Gene. 535:97–100. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kinoshita M, Numata S, Tajima A, et al:
DNA methylation signatures of peripheral leukocytes in
schizophrenia. Neuromolecular Med. 15:95–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu H, Wang B, Su D, et al: The DNA
methylation profile of PLA2G4C gene promoter in schizophrenia.
Psychiatry Res. 200:1079–1081. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Davis KL, Kahn RS, Ko G and Davidson M:
Dopamine in schizophrenia: a review and reconceptualization. Am J
Psychiatry. 148:1474–1486. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Beinfeld MC: An introduction to neuronal
cholecystokinin. Peptides. 22:1197–1200. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wei J and Hemmings GP: The CCK-A receptor
gene possibly associated with auditory hallucinations in
schizophrenia. Eur Psychiatry. 14:67–70. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vaccarino FJ: Nucleus accumbens
dopamine-CCK interactions in psychostimulant reward and related
behaviors. Neurosci Biobehav Rev. 18:207–214. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kemper CM, O’Connor DT and Westlund KN:
Immunocytochemical localization of dopamine-beta-hydroxylase in
neurons of the human brain stem. Neuroscience. 23:981–989. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cimarusti DL, Saito K, Vaughn JE, Barber
R, Roberts E and Thomas PE: Immunocytochemical localization of
dopamine-beta-hydroxylase in rat locus coeruleus and hypothalamus.
Brain Res. 162:55–67. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Srivastava V, Deshpande SN and Thelma BK:
Dopaminergic pathway gene polymorphisms and genetic susceptibility
to schizophrenia among north Indians. Neuropsychobiology. 61:64–70.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guan ZZ, Zhang X, Blennow K and Nordberg
A: Decreased protein level of nicotinic receptor alpha7 subunit in
the frontal cortex from schizophrenic brain. Neuroreport.
10:1779–1782. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Court J, Spurden D, Lloyd S, et al:
Neuronal nicotinic receptors in dementia with Lewy bodies and
schizophrenia: alpha-bungarotoxin and nicotine binding in the
thalamus. J Neurochem. 73:1590–1597. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Freedman R, Hall M, Adler LE and Leonard
S: Evidence in postmortem brain tissue for decreased numbers of
hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry.
38:22–33. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Leonard S, Gault J, Hopkins J, et al:
Association of promoter variants in the alpha7 nicotinic
acetylcholine receptor subunit gene with an inhibitory deficit
found in schizophrenia. Arch Gen Psychiatry. 59:1085–1096. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tsuang DW, Skol AD, Faraone SV, et al;
Veterans Affairs Cooperative Study. Examination of genetic linkage
of chromosome 15 to schizophrenia in a large Veterans Affairs
Cooperative Study sample. Am J Med Genet. 105:662–668. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Freedman R, Leonard S, Gault JM, et al:
Linkage disequilibrium for schizophrenia at the chromosome 15q13–14
locus of the alpha7-nicotinic acetylcholine receptor subunit gene
(CHRNA7). Am J Med Genet. 105:20–22. 2001.
|
|
27
|
Miyoshi K, Honda A, Baba K, et al:
Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia,
participates in neurite outgrowth. Mol Psychiatry. 8:685–694. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Millar JK, Christie S, Anderson S, et al:
Genomic structure and localisation within a linkage hotspot of
Disrupted In Schizophrenia 1, a gene disrupted by a translocation
segregating with schizophrenia. Mol Psychiatry. 6:173–178. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Millar JK, Wilson-Annan JC, Anderson S, et
al: Disruption of two novel genes by a translocation co-segregating
with schizophrenia. Hum Mol Genet. 9:1415–1423. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamada K, Nakamura K, Minabe Y, et al:
Association analysis of FEZ1 variants with schizophrenia in
Japanese cohorts. Biol Psychiatry. 56:683–690. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Prabakaran S, Swatton JE, Ryan MM, et al:
Mitochondrial dysfunction in schizophrenia: evidence for
compromised brain metabolism and oxidative stress. Mol Psychiatry.
9:684–697. 6432004.PubMed/NCBI
|
|
32
|
Marchbanks RM, Ryan M, Day IN, Owen M,
McGuffin P and Whatley SA: A mitochondrial DNA sequence variant
associated with schizophrenia and oxidative stress. Schizophr Res.
65:33–38. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yao JK, Reddy RD and van Kammen DP:
Oxidative damage and schizophrenia: an overview of the evidence and
its therapeutic implications. CNS Drugs. 15:287–310. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rabinovic AD and Hastings TG: Role of
endogenous glutathione in the oxidation of dopamine. J Neurochem.
71:2071–2078. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tosic M, Ott J, Barral S, et al:
Schizophrenia and oxidative stress: glutamate cysteine ligase
modifier as a susceptibility gene. Am J Hum Genet. 79:586–592.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Coyle JT: The glutamatergic dysfunction
hypothesis for schizophrenia. Harv Rev Psychiatry. 3:241–253. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Meador-Woodruff JH, Davis KL and
Haroutunian V: Abnormal kainate receptor expression in prefrontal
cortex in schizophrenia. Neuropsychopharmacology. 24:545–552. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Thompson PM, Rosenberger C and Qualls C:
CSF SNAP-25 in schizophrenia and bipolar illness. A pilot study.
Neuropsychopharmacology. 21:717–722. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hess EJ, Jinnah HA, Kozak CA and Wilson
MC: Spontaneous locomotor hyperactivity in a mouse mutant with a
deletion including the Snap gene on chromosome 2. J Neurosci.
12:2865–2874. 1992.PubMed/NCBI
|
|
40
|
Excoffier L, Laval G and Schneider S:
Arlequin (version 3.0): an integrated software package for
population genetics data analysis. Evol Bioinform Online. 1:47–50.
2007.
|
|
41
|
Coory MD: Comment on: Heterogeneity in
meta-analysis should be expected and appropriately quantified. Int
J Epidemiol. 39:932–933. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kawalec P, Mikrut A, Wísniewska N and Pilc
A: The effectiveness of tofacitinib, a novel Janus kinase
inhibitor, in the treatment of rheumatoid arthritis: a systematic
review and meta-analysis. Clin Rheumatol. 32:1415–1424. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sokolov BP: Expression of NMDAR1, GluR1,
GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal
cortex of ‘neuroleptic-free’ schizophrenics: evidence on reversible
up-regulation by typical neuroleptics. J Neurochem. 71:2454–2464.
1998.PubMed/NCBI
|
|
44
|
Schiffer HH, Swanson GT, Masliah E and
Heinemann SF: Unequal expression of allelic kainate receptor GluR7
mRNAs in human brains. J Neurosci. 20:9025–9033. 2000.PubMed/NCBI
|
|
45
|
Nutt SL, Hoo KH, Rampersad V, et al:
Molecular characterization of the human EAA5 (GluR7) receptor: a
high-affinity kainate receptor with novel potential RNA editing
sites. Receptors Channels. 2:315–326. 1994.PubMed/NCBI
|
|
46
|
Montecucco C, Schiavo G and Pantano S:
SNARE complexes and neuroexocytosis: how many, how close? Trends
Biochem Sci. 30:367–372. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lochman J, Balcar VJ, St’astný F and Serý
O: Preliminary evidence for association between schizophrenia and
polymorphisms in the regulatory regions of the ADRA2A, DRD3 and
SNAP-25 genes. Psychiatry Res. 205:7–12. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Carroll LS, Kendall K, O’Donovan MC, Owen
MJ and Williams NM: Evidence that putative ADHD low risk alleles at
SNAP25 may increase the risk of schizophrenia. Am J Med Genet B
Neuropsychiatr Genet. 150B:893–899. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kawashima K, Kishi T, Ikeda M, et al: No
association between tagging SNPs of SNARE complex genes (STX1A,
VAMP2 and SNAP25) and schizophrenia in a Japanese population. Am J
Med Genet B Neuropsychiatr Genet. 147B:1327–1331. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zheng C, Fu Q, Shen Y and Xu Q:
Investigation of allelic heterogeneity of the CCK-A receptor gene
in paranoid schizophrenia. Am J Med Genet B Neuropsychiatr Genet.
159B:741–747. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Minato T, Tochigi M, Kato N and Sasaki T:
Association study between the cholecystokinin A receptor gene and
schizophrenia in the Japanese population. Psychiatr Genet.
17:117–119. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Sanjuan J, Toirac I, González JC, et al: A
possible association between the CCK-AR gene and persistent
auditory hallucinations in schizophrenia. Eur Psychiatry.
19:349–353. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Tachikawa H, Harada S, Kawanishi Y, Okubo
T and Suzuki T: Linked polymorphisms (-333G>T and -286A>G) in
the promoter region of the CCK-A receptor gene may be associated
with schizophrenia. Psychiatry Res. 103:147–155. 2001.PubMed/NCBI
|
|
54
|
Bakanidze G, Roinishvili M, Chkonia E, et
al: Association of the nicotinic receptor alpha7 subunit gene
(CHRNA7) with schizophrenia and visual backward masking. Front
Psychiatry. 4:1332013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Cabranes JA, Ancín I, Santos JL, et al: No
effect of polymorphisms in the non-duplicated region of the CHRNA7
gene on sensory gating P50 ratios in patients with schizophrenia
and bipolar disorder. Psychiatry Res. 205:276–278. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ancín I, Barabash A, Vázquez-Álvarez B, et
al: Evidence for association of the non-duplicated region of CHRNA7
gene with bipolar disorder but not with Schizophrenia. Psychiatr
Genet. 20:289–297. 2010.PubMed/NCBI
|
|
57
|
Iwata Y, Nakajima M, Yamada K, et al:
Linkage disequilibrium analysis of the CHRNA7 gene and its
partially duplicated region in schizophrenia. Neurosci Res.
57:194–202. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Joo EJ, Lee KY, Kim HS, Kim SH, Ahn YM and
Kim YS: Genetic association study of the alpha 7 nicotinic receptor
(CHRNA7) with the development of schizophrenia and bipolar disorder
in Korean population. Psychiatry Investig. 7:196–201. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Hui L, Zhang X, Yu YQ, et al: Association
between DBH 19 bp insertion/deletion polymorphism and cognition in
first-episode schizophrenic patients. Schizophr Res. 147:236–240.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhou N, Yu Q, Li X, et al: Association of
the dopamine β-hydroxylase 19 bp insertion/deletion polymorphism
with positive symptoms but not tardive dyskinesia in schizophrenia.
Hum Psychopharmacol. 28:230–237. 2013.
|
|
61
|
Yamamoto K, Cubells JF, Gelernter J, et
al: Dopamine beta-hydroxylase (DBH) gene and schizophrenia
phenotypic variability: a genetic association study. Am J Med Genet
B Neuropsychiatr Genet. 117B:33–38. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Koga M, Ishiguro H, Horiuchi Y, et al:
Failure to confirm the association between the FEZ1 gene and
schizophrenia in a Japanese population. Neurosci Lett. 417:326–329.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Hodgkinson CA, Goldman D, Ducci F, et al:
The FEZ1 gene shows no association to schizophrenia in Caucasian or
African American populations. Neuropsychopharmacology. 32:190–196.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Kilic G, Ismail Kucukali C, Orhan N, et
al: Are GRIK3 (T928G) gene variants in schizophrenia patients
different from those in their first-degree relatives? Psychiatry
Res. 175:43–46. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ahmad Y, Bhatia MS, Mediratta PK, et al:
Association between the ionotropic glutamate receptor kainate3
(GRIK3) Ser310Ala polymorphism and schizophrenia in the Indian
population. World J Biol Psychiatry. 10:330–333. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Lai IC, Liou YJ, Chen JY and Wang YC: No
association between the ionotropic glutamate receptor kainate 3
gene ser310ala polymorphism and schizophrenia. Neuropsychobiology.
51:211–213. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Begni S, Popoli M, Moraschi S, Bignotti S,
Tura GB and Gennarelli M: Association between the ionotropic
glutamate receptor kainate 3 (GRIK3) ser310ala polymorphism and
schizophrenia. Mol Psychiatry. 7:416–418. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Hanzawa R, Ohnuma T, Nagai Y, et al: No
association between glutathione-synthesis-related genes and
Japanese schizophrenia. Psychiatry Clin Neurosci. 65:39–46. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Ma J, Li DM, Zhang R, et al: Genetic
analysis of glutamate cysteine ligase modifier (GCLM) gene and
schizophrenia in Han Chinese. Schizophr Res. 119:273–274. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Kishi T, Ikeda M, Kitajima T, et al:
Glutamate cysteine ligase modifier (GCLM) subunit gene is not
associated with methamphetamine-use disorder or schizophrenia in
the Japanese population. Ann NY Acad Sci. 1139:63–69. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Matsuzawa D, Hashimoto K, Hashimoto T, et
al: Association study between the genetic polymorphisms of
glutathione-related enzymes and schizophrenia in a Japanese
population. Am J Med Genet B Neuropsychiatr Genet. 150B:86–94.
2009. View Article : Google Scholar : PubMed/NCBI
|
